DE69902657T2 - Hydroxyomeprazol-enthaltende zubereitungen und verwendungen - Google Patents

Hydroxyomeprazol-enthaltende zubereitungen und verwendungen

Info

Publication number
DE69902657T2
DE69902657T2 DE69902657T DE69902657T DE69902657T2 DE 69902657 T2 DE69902657 T2 DE 69902657T2 DE 69902657 T DE69902657 T DE 69902657T DE 69902657 T DE69902657 T DE 69902657T DE 69902657 T2 DE69902657 T2 DE 69902657T2
Authority
DE
Germany
Prior art keywords
hydroxyomeprazole
pharmaceutically acceptable
acceptable salt
pharmaceutical composition
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69902657T
Other languages
German (de)
English (en)
Other versions
DE69902657D1 (de
Inventor
A. Handley
E. Yelle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma America Inc
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Publication of DE69902657D1 publication Critical patent/DE69902657D1/de
Application granted granted Critical
Publication of DE69902657T2 publication Critical patent/DE69902657T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69902657T 1998-05-05 1999-05-05 Hydroxyomeprazol-enthaltende zubereitungen und verwendungen Expired - Fee Related DE69902657T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8425898P 1998-05-05 1998-05-05
PCT/US1999/009814 WO1999056746A1 (en) 1998-05-05 1999-05-05 Hydroxyomeprazole compositions and uses

Publications (2)

Publication Number Publication Date
DE69902657D1 DE69902657D1 (de) 2002-10-02
DE69902657T2 true DE69902657T2 (de) 2003-04-30

Family

ID=22183810

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69902657T Expired - Fee Related DE69902657T2 (de) 1998-05-05 1999-05-05 Hydroxyomeprazol-enthaltende zubereitungen und verwendungen

Country Status (9)

Country Link
US (2) US6294586B1 (https=)
EP (1) EP1082114B1 (https=)
JP (1) JP2003517434A (https=)
AT (1) ATE222764T1 (https=)
AU (1) AU748872B2 (https=)
CA (1) CA2330049A1 (https=)
DE (1) DE69902657T2 (https=)
ES (1) ES2182524T3 (https=)
WO (1) WO1999056746A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6420435B1 (en) * 1999-11-01 2002-07-16 Joe S. Wilkins, Jr. Method for treating gastrointestinal disorders
US6987123B2 (en) 2001-07-26 2006-01-17 Cadila Healthcare Limited Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine
US7041706B2 (en) * 2002-04-19 2006-05-09 Wilkins Jr Joe S Method for treating crohn's disease
WO2004064719A2 (en) * 2003-01-24 2004-08-05 State Of Israel, Ministry Of Agriculture Synergistic compositions and methods for potentiating anti-oxidative activity
WO2005032554A1 (en) 2003-10-03 2005-04-14 Astron Research Pvt. Ltd A novel transmucosal delivery system
ES2281292B1 (es) * 2006-03-08 2008-06-16 Quimica Sintetica S.A. Nuevas sales de esomeprazol. procedimiento de preparacion y composiciones farmaceuticas que las comprenden.

Also Published As

Publication number Publication date
WO1999056746A1 (en) 1999-11-11
EP1082114A1 (en) 2001-03-14
AU748872B2 (en) 2002-06-13
EP1082114B1 (en) 2002-08-28
US6294586B1 (en) 2001-09-25
ES2182524T3 (es) 2003-03-01
CA2330049A1 (en) 1999-11-11
AU3971699A (en) 1999-11-23
ATE222764T1 (de) 2002-09-15
US6498171B2 (en) 2002-12-24
JP2003517434A (ja) 2003-05-27
DE69902657D1 (de) 2002-10-02
US20020010196A1 (en) 2002-01-24

Similar Documents

Publication Publication Date Title
DE69812089T2 (de) Pharmazeutische omeprazol-formulierung
DE69628551T2 (de) Oral anzuwendende pharmazeutische dosierungsformen,enthaltend einem protonenpunpeninibitor und einen nicht-steriodalen antiinflamatorischen wirkstoff
DE69832816T2 (de) Orale pharmazeutische dosierungsform mit verlängerter wirkstofffreisetzung
DE69624907T3 (de) Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten
DE69533470T2 (de) Aus mehreren einzeleinheiten zusammengesetztes pharmazeutisches präparat, das einen protonenpumpeninhibitor enthält
DE69624910T2 (de) Orale pharmazeutische dosierungsformen die einen protonenpumpeninhibitor und ein prokinetisches mittel enthalten
DE69630286T2 (de) Aus mehreren einzeleinheiten zusammengesetzte dosierungsformen enthaltend einem protonen pumpen inhibitor
DE69629755T2 (de) Irbesartanhaltiges Arzneimittel
DE60002042T2 (de) Neue kristallinische form des kaliumsalzes des (s)-omeprazols
DE3783394T2 (de) Arzneizubereitung zur oralen anwendung.
DE69909316T2 (de) Pharmazeutische formulierung mit omeprazol
EP1485094B2 (de) Oral zu applizierende darreichungsform für 3- [(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amino] -propionsäure-ethylester oder dessen salze
DE3751851T2 (de) Verwendung von spezifischem Kernmaterial und Schichten zur Herstellung pharmazeutischer Formulierungen, die stabil gegen die Verfärbung säurelabiler Verbindungen sind
DE60029712T2 (de) Feste oral anzuwendende Arzneizubereitung mit gesteuerter Wirkstoffabgabe enthaltend eine säureempfindliche Benzimidazolverbindung
DE2845326C2 (de) Verwendung einer spezifischen mikrodispersen, amorphen, porösen Kieselsäure zur Herstellung von Digoxin enthaltenden Tabletten mit stark beschleunigter Wirkstoff-Freisetzung
DE3720757A1 (de) Dhp-manteltablette
DE29623938U1 (de) Neue stabile galenische Formulierungen, enthaltend eine säureempfindliche Benzimidazolverbindung
DE69814850T2 (de) Paracetamol enthaltende schlickbare tablette
DE69425589T2 (de) Kombiniertes antipyretisches und analgetisches arzneimittel
EP1509207A1 (de) Pharmazeutische zusammensetzung, enthaltend oxcarbazepin mit kontrollierter wirkstofffreisetzung
DE69902657T2 (de) Hydroxyomeprazol-enthaltende zubereitungen und verwendungen
DE2732335C2 (de) Tablette zur enteralen Verabreichung von Indolyloxyalkanolamin-Derivaten
DE4340774A1 (de) Moenomycin und dessen Derivate zur Herstellung von Arzneimitteln, sowie Arzneimittel mit einem Gehalt an Moenomycin oder dessen Derivaten
EP2161022B1 (de) Herstellung von Phosphatbindern und auf diese Weise hergestellte Phosphatbinder
DE69903315T2 (de) Pharmazeutische zubereitungen enthaltend hydroxylansoprazol und deren verwendungen

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee